# OnCo record her2-brain-metastases (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/her2-brain-metastases/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "her2-brain-metastases" ;
  schema:name "HER2-positive brain metastases"@en ;
  schema:description "Up to half of women with metastatic HER2-positive breast cancer develop brain metastases, because antibodies control the body but historically not the brain."@en ;
  schema:url <https://onco.cc/terms/her2-brain-metastases/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Brain_metastasis> ;
  schema:citation <https://clinicaltrials.gov/study/NCT02614794>, <https://clinicaltrials.gov/study/NCT04739761> ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/sbrt/>, <https://onco.cc/technologies/mri/> ;
  onco:drugs <https://onco.cc/drugs/tucatinib/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/drugs/neratinib/> ;
  onco:trials <https://onco.cc/trials/her2climb/>, <https://onco.cc/trials/destiny-breast12/> .